Funds holding KalVista Pharmaceuticals Inc
ISIN US4834971032 · United States · LEI 529900Q7IDA3WUGRZA51
- Fund holders
- 36
- Of which ETFs
- 15 21 other funds
- Value held
- ≈ 65.8M $ 58M $ · 549.7K € · 67.4M SEK
- Share of capital
- 4.9 % of 51.2M shares on Mar 18, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| THE ARBITRAGE FUND ARBITRAGE FUNDS | 690,618 | 18.6M $ | 2.20 % | 1.35 % | as of May 31, 2026 ↗ |
| SEB Läkemedelsfond SEB Funds AB | 351,305 | 67.4M SEK | 0.42 % | 0.69 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 212,587 | 5.7M $ | 0.10 % | 0.42 % | as of May 29, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 204,298 | 5.5M $ | 0.01 % | 0.40 % | as of May 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 196,870 | 5.3M $ | 0.03 % | 0.38 % | as of May 31, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 190,123 | 5.1M $ | 0.02 % | 0.37 % | as of May 31, 2026 ↗ |
| AltShares Merger Arbitrage ETF AltShares Trust | 90,263 | 2.4M $ | 2.35 % | 0.18 % | as of May 31, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 82,908 | 2.2M $ | 0.01 % | 0.16 % | as of May 31, 2026 ↗ |
| iShares ESG Aware MSCI USA Small-Cap ETF iShares Trust | 76,735 | 2.1M $ | 0.09 % | 0.15 % | as of May 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 74,994 | 2M $ | 0.00 % | 0.15 % | as of May 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 60,035 | 1.6M $ | 0.00 % | 0.12 % | as of May 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 52,105 | 1.4M $ | 0.87 % | 0.10 % | as of May 31, 2026 ↗ |
| Water Island Event-Driven Fund ARBITRAGE FUNDS | 37,497 | 1M $ | 2.01 % | 0.07 % | as of May 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 36,056 | 968.8K $ | 0.06 % | 0.07 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 31,757 | 853.3K $ | 0.00 % | 0.06 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 30,371 | 816.1K $ | 0.01 % | 0.06 % | as of May 31, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 23,406 | 628.9K $ | 0.00 % | 0.05 % | as of May 31, 2026 ↗ |
| Small Cap Index Fund VALIC Co I | 15,296 | 411K $ | 0.03 % | 0.03 % | as of May 31, 2026 ↗ |
| ProShares Merger ETF ProShares Trust | 13,850 | 372.1K $ | 2.34 % | 0.03 % | as of May 31, 2026 ↗ |
| AltShares Event-Driven ETF AltShares Trust | 9,139 | 245.6K $ | 2.00 % | 0.02 % | as of May 31, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 4,724 | 126.9K $ | 0.67 % | 0.01 % | as of May 31, 2026 ↗ |
| SIIT EXTENDED MARKET INDEX FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 4,700 | 126.3K $ | 0.01 % | 0.01 % | as of May 31, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 3,117 | 83.8K $ | 0.00 % | 0.01 % | as of May 31, 2026 ↗ |
| Federated Hermes Global Allocation Fund Federated Hermes Global Allocation Fund | 2,767 | 74.3K $ | 0.03 % | 0.01 % | as of May 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 2,736 | 73.5K $ | 0.11 % | 0.01 % | as of May 31, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 1,996 | 53.6K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 1,870 | 50.2K $ | 0.07 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 1,806 | 48.5K $ | 0.03 % | 0.00 % | as of May 31, 2026 ↗ |
| Columbia Integrated Small Cap Growth Fund Columbia Funds Series Trust II | 1,793 | 48.2K $ | 0.15 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 1,429 | 38.4K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 1,412 | 37.9K $ | 0.02 % | 0.00 % | as of May 31, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 1,301 | 35K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,162 | 31.2K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 36 | 967.3 $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 12 | 322.4 $ | 0.03 % | 0.00 % | as of May 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 549.7K € | 0.67 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| AltShares Merger Arbitrage ETF AltShares Trust | 2.35 % | as of May 31, 2026 ↗ |
| ProShares Merger ETF ProShares Trust | 2.34 % | as of May 31, 2026 ↗ |
| THE ARBITRAGE FUND ARBITRAGE FUNDS | 2.20 % | as of May 31, 2026 ↗ |
| Water Island Event-Driven Fund ARBITRAGE FUNDS | 2.01 % | as of May 31, 2026 ↗ |
| AltShares Event-Driven ETF AltShares Trust | 2.00 % | as of May 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.87 % | as of May 31, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.67 % | as of May 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.67 % | as of Dec 31, 2025 ↗ |
| SEB Läkemedelsfond SEB Funds AB | 0.42 % | as of Mar 31, 2026 ↗ |
| Columbia Integrated Small Cap Growth Fund Columbia Funds Series Trust II | 0.15 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 34 | -101 | 2,159,769 | -82.4 % |
| 2026Q2 | 135 | +13 | 12,238,532 | +11.6 % |
| 2026Q1 | 122 | +3 | 10,970,157 | +3.5 % |
| 2025Q4 | 119 | 0 | 10,594,944 | +2.7 % |
| 2025Q3 | 119 | 0 | 10,321,235 | +2.8 % |
| 2025Q2 | 119 | +1 | 10,035,854 | -4.4 % |
| 2025Q1 | 118 | -4 | 10,499,830 | +0.4 % |
| 2024Q4 | 122 | -1 | 10,453,874 | +15.1 % |
| 2024Q3 | 123 | -2 | 9,086,140 | +59.0 % |
| 2024Q2 | 125 | +5 | 5,713,251 | +9.7 % |
| 2024Q1 | 120 | -4 | 5,209,673 | +12.9 % |
| 2023Q4 | 124 | 4,613,729 |
Institutional managers
175 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Venrock Adviser, LLC | 6,474,485 | 130.3M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 4,961,108 | 99.9M $ | as of Mar 31, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,768,712 | 96M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 4,573,530 | 92.1M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,795,897 | 76.4M $ | as of Mar 31, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,876,407 | 57.9M $ | as of Mar 31, 2026 |
| Capital World Investors | 2,808,583 | 56.5M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 2,136,940 | 43M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 1,955,844 | 39.4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,912,146 | 38.5M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 1,850,000 | 37.2M $ | as of Mar 31, 2026 |
| Parkman Healthcare Partners LLC | 1,835,506 | 36.9M $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 1,820,954 | 36.7M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 1,509,920 | 30.4M $ | as of Mar 31, 2026 |
| Octagon Capital Advisors LP | 1,450,000 | 29.2M $ | as of Mar 31, 2026 |
| EMERALD ADVISERS, LLC | 1,264,023 | 25.4M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 1,236,000 | 24.9M $ | as of Mar 31, 2026 |
| Elmind Capital, LP | 1,021,300 | 20.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 996,235 | 20.1M $ | as of Mar 31, 2026 |
| Squadron Capital Management LLC | 985,100 | 19.8M $ | as of Mar 31, 2026 |
| Spruce Street Capital LP | 897,681 | 18.1M $ | as of Mar 31, 2026 |
| Freestone Grove Partners LP | 882,906 | 17.8M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 824,293 | 16.6M $ | as of Mar 31, 2026 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 805,762 | 16.2M $ | as of Mar 31, 2026 |
| GREAT POINT PARTNERS LLC | 675,000 | 13.6M $ | as of Mar 31, 2026 |
Declared shareholders of KalVista Pharmaceuticals Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC and 5 others | 0.00 % | 0 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding KalVista Pharmaceuticals Inc". https://titelia.com/en/stocks/kalvista-pharmaceuticals-inc-US4834971032